Inogen (INGN) Total Current Liabilities (2013 - 2026)
Inogen (INGN) reported Total Current Liabilities of $61.4 million for Q1 2026, down 6.12% year-over-year from $65.5 million in Q1 2025, and down 3.29% quarter-over-quarter from $63.5 million in Q4 2025.
Inogen (INGN) Total Current Liabilities (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Total Current Liabilities data on file, last reported at $61.4 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $61.4 million, down 6.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.4 million (down 6.12% YoY), and the FY2025 annual result was $63.5 million, down 17.15% from the prior year.
- Total Current Liabilities fell to $61.4 million in Q1 2026 per INGN's latest filing, from $63.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $76.7 million in Q4 2024 and troughed at $59.3 million in Q2 2022.
- A 5-year average of $66.1 million and a median of $65.3 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities climbed 21.59% in 2024, then retreated 17.15% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $65.3 million in 2022, then advanced by 10.94% to $72.5 million in 2023, then increased by 5.78% to $76.7 million in 2024, then fell by 17.15% to $63.5 million in 2025, then declined by 3.29% to $61.4 million in 2026.
- Business Quant data shows INGN's Total Current Liabilities at $61.4 million in Q1 2026, $63.5 million in Q4 2025, and $64.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 1.41 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 8.53 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.22 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Inogen | 174.59 Mn | 80.18 Mn | 37.86 Mn | 61.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.45 Mn |
| Dec 31, 2025 | 63.54 Mn |
| Sep 30, 2025 | 64.94 Mn |
| Jun 30, 2025 | 67.07 Mn |
| Mar 31, 2025 | 65.45 Mn |
| Dec 31, 2024 | 76.69 Mn |
| Sep 30, 2024 | 72.40 Mn |
| Jun 30, 2024 | 72.19 Mn |
| Mar 31, 2024 | 73.91 Mn |
| Dec 31, 2023 | 72.50 Mn |
| Sep 30, 2023 | 60.38 Mn |
| Jun 30, 2023 | 59.37 Mn |
| Mar 31, 2023 | 63.38 Mn |
| Dec 31, 2022 | 65.35 Mn |
| Sep 30, 2022 | 65.74 Mn |
| Jun 30, 2022 | 59.34 Mn |
| Mar 31, 2022 | 59.82 Mn |
| Dec 31, 2021 | 61.51 Mn |
| Sep 30, 2021 | 59.93 Mn |
| Jun 30, 2021 | 61.84 Mn |